News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18718)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Genetown
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) On Nov. 1
The granted option has an exercise price of $61.83 per share, which is equal to the closing price of Sage’s common stock on November 1, 2017.
November 3, 2017
·
2 min read
Business
Fluicell Has In-Licensed the Dynaflow Resolve Secondary Ion Channel Screening Platform Technology From Cellectricon
Fluicell is extremely pleased to announce the signing of a license agreement with Cellectricon, granting the exclusive right, inter alia, to sell the Dynaflow Resolve technology worldwide and to use the related IP rights.
November 3, 2017
·
3 min read
BioMidwest
ViewRay’s MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
ViewRay announced today that the company’s MRIdian Linac has been selected for installation at Rigshospitalet and Herlev Hospitals in Denmark, as part of a competitive bid and comprehensive technology review.
November 3, 2017
·
3 min read
Business
New License Agreement Sets Course for Development of Cancer Drugs With Targeting Ability
The license agreement grants the spin-out company ADCendo worldwide rights to explore and commercialize certain inventions made by researchers at the Finsen Laboratory related to ADC drugs targeting the novel uPARAP receptor.
November 3, 2017
·
6 min read
Biotech Bay
Patients and Physicians Prefer Zip Surgical Skin Closure Over Staples in First Head-to-Head Comparison of the Device versus Staples During Bilateral Knee Surgery
Results were presented today as a poster at the American Academy of Hip and Knee Surgery Annual Meeting (AAHKS) by Rodney Benner, MD, of the Shelbourne Knee Center in Indianapolis.
November 3, 2017
·
2 min read
FDA
Medacta Wins FDA Nod and First Surgeries Utilizing 3DMetal Tibial Cones for Knee Revision
The 3DMetal Tibial Cones can be used for structural support in areas of bone deficiencies that may compromise revision implant fixation.
November 3, 2017
·
3 min read
Genetown
Myomo Enters Canadian Market
Myomo announced that its Application for a Canadian Medical Device License has been approved by Health Canada.
November 3, 2017
·
4 min read
Biotech Beach
BIOLASE Announces Terms of Rights Offering
Upon commencement of the rights offering on November 8, 2017, the Company will distribute to its shareholders as of 5:00 p.m., Eastern Time, on November 8, 2017.
November 3, 2017
·
4 min read
Business
Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members
Bob Duggan has been appointed Chairman of the Board; Ken Clark, Dr. Thomas Fogarty and Manmeet S. Soni have been appointed as independent directors, effective November 2, 2017.
November 3, 2017
·
7 min read
Biotech Beach
ReShape Lifesciences Presents New Data on Obesity Technologies
The presentation discussed 342 patients that were implanted with the ReShape Integrated Dual Balloon at a multicenter bariatric practice.
November 3, 2017
·
6 min read
Previous
2 of 13
Next